.peptides
Is .peptides a real TLD? Who’s applying to run it?
Nobody has applied for .peptides in its own right, as of 18 November 2026. Radix named .peptides as a backup string for its .agentic application. ICANN’s list shows it as deactivated: the application cannot move to it.
Nobody has applied for .peptides in its own right.
Will names sell?
A narrow label for peptide sellers and biotech projects; memorable inside that niche, but few would make it their main web address.
Last round the AI scored the 2012 strings blind to their fate. Strings it scored 60 or more hold a median 27,168 names today; those under 30, a median of 30. .peptides’s closest 2012 strings hold .tires 1K and .diet 1K.
The nearest 2012 strings, and how many names each holds today
The closest 2012 string, .tires, held 1,365 names, June 2026. .diet held 1,391. Chosen by AI from every string in the 2012 round, without being told what happened to any of them.
- .connectors
Same bet as .peptides: a narrow, technical commodity-class plural that only pays off if a specialized B2B supplier trade (not consumers, not a community, not one brand) decides a dedicated namespace is worth putting its selling identity on.
Also a single-product-category plural generic whose entire registrant base is sellers and distributors of that one thing, but it bets on a mature mass-retail aftermarket rather than on a thinly-commercialized specialist supply chain.
Closest parallel on the demand side .peptides shares with wellness commerce: a health-claim category generic where the registrants are vendors monetizing an unlicensed, regulator-watched consumer category, though it is an outcome word rather than the name of the substance being sold.
peptide and wellness-supplement sellers, compounding and research-chemical vendors, and small biotech or peptide-therapeutics projects wanting a descriptive secondary address
What a .peptides domain is
.peptides is not a TLD yet. It is a string on our record of the ICANN 2026 new gTLD round, in our Commerce category. Nobody has applied for .peptides in its own right. It is named on ICANN’s list as part of an application for another string.
Is the .peptides domain extension real yet?
.peptides is not yet a domain extension you can register: nothing resolves under it, and no registrar sells names in it. Nobody has applied for it on the public record; the ICANN 2026 new gTLD round is the process that would decide whether it becomes one.
When can you buy a .peptides domain?
You can’t yet. A .peptides name can only be registered once the string is delegated (added to the DNS root) and its registry opens.
Is .peptides a real TLD?
Not yet. .peptides is not in the DNS root, so nothing resolves under it. It’s here because ICANN’s list names .peptides as part of an application for another string. Every entry on this page links to its source.
- Band chosen: 10-29 (vanity/joke/narrow), at the top of the band. The string names one product class inside health and biotech, and the online market around it is real but small: direct-to-consumer peptide and wellness-supplement storefronts, research-peptide vendors, and early-stage peptide-therapeutics companies. That gives it a plausible descriptive use (a shop or a research site could carry the word as its label), which keeps it above the 1-9 band. It is not in the 30-49 band because, by analogy with other specific-noun generic TLDs such as .bio, .pharmacy, .clinic or product-noun strings like .toys and .guitars, adoption of narrow category nouns has tended to be thin, with most serious operators in the niche keeping a .com as primary identity and treating the category string as a redirect or vanity address at best; registration volume on price is unlikely for a string this specialized, and an aftermarket would be close to nonexistent. The applicant on the record is Radix Technologies Inc SEZC, filed as a standard application and recorded as a replacement string for .agentic; the record shows zero contention. That status is stated neutrally and matters only for how committed a launch program might be, which is assumed away here. Main market uncertainty: whether direct-to-consumer peptide commerce stays viable and reputable online over the next five years under tightening regulatory attention in major markets, and whether sellers in that space would choose a category TLD over the default of .com; a reputational drift toward gray-market sellers would push the string toward the lower part of the band, while a legitimized wellness-peptide retail wave could lift it toward 30-35. Analogy inferences are flagged as such; no registration figures are asserted.